Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05258981 · ClinicalTrials.gov registry record · NA

The Relationship Between Brain MRI Phenotypes, Genes and Cognitive Outcome in CHD Adults

A NA study of Congenital Heart Disease, sponsored by Boston Children's Hospital.

Recruiting
Registry status
NA
Development phase
225
Enrollment target
1
Study location

NCT05258981 is a NA study of Congenital Heart Disease that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 225 participants, below the 470-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05258981, a NA study of Congenital Heart Disease, is actively recruiting participants, sponsored by Boston Children's Hospital.

RECRUITING
Registry status
NA
Development phase
225 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this proposal is to perform novel MRI analyses to determine the brain organizational changes associated with altered executive function and the modulating role of variants in neuroresilience and hypoxia response genes in adults with d-transposition of the great arteries (d-TGA).

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST MRI

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2022-07-01
Est. Completion 2026-06
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT05258981

The ClinicalTrials.gov registry entry for NCT05258981 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 470-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (52% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.

NCT05258981 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05258981 about?

NCT05258981 is a clinical study titled "The Relationship Between Brain MRI Phenotypes, Genes and Cognitive Outcome in CHD Adults". The main purpose of this proposal is to perform novel MRI analyses to determine the brain organizational changes associated with altered executive function and the modulating role of variants in neuroresilience and hypoxia response genes in adults with d-transposition of the great arteries (d-TGA).

What is the current status of trial NCT05258981?

This trial is currently recruiting. It is a NA study. The enrollment target is 225 participants. The study started on 2022-07-01. Estimated completion is 2026-06.

What conditions does trial NCT05258981 study?

This clinical trial studies the following conditions: Congenital Heart Disease.

What interventions are being tested in trial NCT05258981?

The interventions under investigation include: MRI (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05258981?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05258981 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congenital Heart Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.